Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Baricitinib shows promise for treating various skin conditions beyond alopecia areata.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Axitinib treatment turned a man's grey hair back to black.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Baricitinib is effective and safe for treating alopecia areata.

Etanercept effectively treated a severe skin condition when other treatments failed.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Twice-weekly 5 mg betamethasone helps hair regrowth in alopecia areata.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.